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METHODS
Twenty-seven consecutive female patients ranging in age from 18.75 years. to 54.5 years (average age, of 33.3 yrs) underwent SAL that included contouring of their back and posterior flanks. The patients in this group had a body mass index (BMI) range of 18.8 to 30.1, with an average BMI of 24.3. The volume of wetting solution used was approximately a 1:1 ratio of infiltrate to aspirate and consisted of 1 mg of epinephrine 1:1000/liter of normal saline. There was approximately a 15-minute interval between the infiltration of the wetting solution and the suction phase to allow for the vasoconstriction effects of the epinephrine to take place. Mercedes-type lipoplasty cannulas (3.5 mm and 3 mm) were used, and general anesthesia was used in all cases. The aspirate corresponding to the back and posterior flank lipoplasty was kept separate and sent for analysis. The total volume of aspirate ranged from 1250 mL to 5250 mL (average, 3366 mL). The back and posterior flank portion of the aspirate volume ranged from 450 mL to 1400 mL (average, 768 mL).
Thirty consecutive female patients ranging in age from 18.5 years to 70.3 years (average age, 41.9 yrs) underwent third-generation internal UAL using the VAS-ER device (Sound Surgical Technologies, Louisville, CO). The BMI range in this group was 19.6 to 33.7 (average BMI, 25.6). All cases included lipoplasty of the back and posterior flanks, and the aspirate corresponding to those anatomic areas was kept separate and sent for analysis.
The total volume of aspirate ranged from 1600 mL to 9200 mL (average, 5755 mL). The portion of aspirate volume corresponding to the back and posterior flanks ranged from 800 mL to 4200 mL (average, 2450 mL). For the purposes of this study, the wetting solution used also consisted of 1 mg of epinephrine1:1000/L of normal saline at a 1:1 ratio of infiltrate to aspirate. (We typically use a ratio of 3:1 infiltrating solution to aspirate.) There was also an approximately 15-minute interval following the infiltration of the wetting solution to allow for the vasoconstriction effects to take place. For the purposes of this study, the amplitude setting on the device was 90% continuous VASER mode applied for approximately 1 minute per 100 mL of infiltrating solution used. (Our usual VASER times are approximately 50% to 60% longer). The VASER probes used were mainly 3.7-mm 2-ring and 2.9-mm 3-ring. VentX cannulas (3.7-and 3.0-mm; Sound Surgical Technologies) were used in all of the VASER-assisted lipoplasty (VAL) cases. All cases were performed under general anesthesia. Informed consent was obtained from all patients in both the SAL and VAL groups.
The aspirate from the back and posterior flanks was chosen for analysis because these are tight, fibrous, anatomic areas that are associated with greater blood loss during lipoplasty procedures (Figure 1) . The aspirate analysis consisted of complete blood counts after separation of the fat. This was performed by an independent laboratory on a Beckman Coulter LH 750 blood analyzer (Fullerton, CA). Normal values on this analyzer are 12 to 16 gm/dl for hemoglobin and 37% to 47% for hematocrit. Because the main purpose of the study was to document and compare blood loss in the lipoplasty aspirates, only the hemoglobin and hematocrit values of the complete blood counts were evaluated. 
RESULTS
The hematocrit values for the SAL aspirate ranged from 2% to 7.2% (mean, 3.98%) compared to the VAL aspirate, which had a hematocrit range of 0.3% to 1.1% (mean, 0.61%). The hemoglobin content of the SAL aspirate ranged from 1.2 to 3.4 g/dl (mean, 2.23 g/dl). By comparison, the hemoglobin content of the VAL aspirate ranged from 0.01 to 0.9 g/dl (mean, 0.3 g/dl). The complete raw data is shown in Table 1 . The mean hemoglobin content of SAL aspirate was 7.5 times greater than in the VAL aspirate. The mean hematocrit value for SAL aspirate was 6.5 times higher than in the aspirate from the VAL group. VAL yielded a more consistent aspirate with significantly less dispersion of both hemoglobin and hematocrit values, as depicted in Figure 2 . The data were subjected to an independent t test for statisti- cal significance. The t score for the hematocrit values was ϩ13.13 and for hemoglobin +16.31, with P < .0001 for both hematocrit and hemoglobin, confirming that the data were highly statistically significant.
The back and posterior flanks have traditionally been associated with a high degree of ecchymosis in the early postoperative period following traditional lipoplasty (Figures 3 and 4) . Digital photography of patients who 6 ). This substantiates previous similar clinical findings by Jewell et al. 5 and de Souza Pinto et al. 15 None of the patients in this study sustained any VASER-related complications.
DISCUSSION
When all parameters are kept equal, the amount of blood in lipoplasty aspirate is location-dependent in a given patient. Tight, fibrous anatomic areas, such as the back and posterior flanks, are associated with a greater amount of blood loss during lipoplasty procedures than "soft areas," such as the lower abdomen or medial thighs. VAL was always associated with a cleaner aspirate; however, in the "soft areas" the blood content of the aspirate was only slightly lower when compared to SAL. It is in the posterior flanks and back areas where the significant differences between VAL and SAL become apparent. Our data, based on aspirate from these anatomic areas, quantitatively confirms previous clinical observations that VAL is associated with significantly less blood loss than SAL. When using bloody aspirate as the "end point" before removal of the desired amount of aspirate in posterior trunk lipoplasty, we were able to remove an average of 3.1 times more aspirate from the back and posterior flanks by using VAL as compared with SAL before the end point was reached.
CONCLUSION
We conclude that VAL should be considered for patients 
